COVID-19 mortality varies with demographic profile

NewsGuard 100/100 Score

The COVID-19 pandemic is slamming down hard on many countries of the world with its second wave. Researchers are still attempting to measure the impact accurately, using parameters such as the case fatality rate, the crude death rate, and the standardized fatality rates.

However, a new study shows that even these still show substantial variation when broken down by sex and age.

COVID-19

SARS-CoV-2 Virus. Image Credit: Andrii Vodolazhskyi/Shutterstock.com

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

The effects of COVID-19 have resulted in a high number of deaths and severely ill patients as well as gross societal and economic disruption. However, the overall impact may have been less in Asia and Africa, for instance, compared to the developed world. Even in developed societies, its heterogeneous outcomes are obvious.

Thus, researchers are still searching for better and more accurate indicators to demonstrate exactly how these infections are affecting the world. Popular media dealing with such displays include the Worldometer or Our World in Data pages on the Internet.

With this type of graphic and data-rich reporting, one of the most commonly used indicators seems to be the number of deaths per million people, when it comes to making comparisons between nations as to the COVID-19 impact.

However, this type of indicator does not consider the characteristics of the individuals or groups that were hit by fatal outcomes, such as age, sex, social and economic attributes, and their access to health care, for instance.

Study Details

The current study, published in the preprint server medRxiv* in December 2020, draws a picture of how infection-related mortality affects two different countries in Latin America. This helps to understand the differences in the impact of the virus on people in different groups who share the same geographic space and have similar population numbers.

The two selected countries are Argentina and Colombia. The first Argentinian patient was reported to have tested positive on March 2, 2020. The corresponding date for Colombia was on March 6.

At the time of the paper, these two countries reported ~1.3 and ~1.2 million cases, for Argentina and Colombia respectively, within 9 months. The number of COVID-19-related deaths was ~35,000 and ~33,000, respectively.

This similar-appearing picture reveals several differences, however, when picked apart. To demonstrate this, the researchers used data from the daily report of the Argentinian Health Ministry and the Colombian National Health Institute, between January 1 to September 30, 2020.

Image Credit: https://www.medrxiv.org/content/10.1101/2020.11.30.20239947v1.full.pdf

Measures of COVID-19 Severity

The standard measure of pandemic severity is the case fatality ratio (CFR) which is the ratio of the deaths to the positive cases. The death rate due to COVID-19 is difficult to calculate since the period of the study covers only 7 months and not a whole year, which is required for this measure – the ratio of deaths to the mean population number in one year, or the person-years.

The researchers therefore resorted to a partial crude death rate, PCDR, rather than adjust the period of exposure assuming the same proportion of deaths will occur.

The researchers only used case numbers, population numbers, and deaths between 30 and 99, to avoid the effects of outliers, such as the very low mortality in younger individuals and the increased death rates in those aged 100 or above.

Increased Female Mortality in Colombia

They found a crude death rate of about 52 in both countries, while the crude CFR varies by about 0.75 points per 1,000. This index stood at 28.4 and 29.2 for Argentina and Colombia, respectively. Both parameters are higher for men, but more significantly in Colombia.

The difference in CFR for women is ~8.4 points per 1,000 and for men, ~22.5, between the two countries. However, the CFR and CDR are both higher for women in Argentina compared to Colombia, while the trend is reversed for men.

When compared with data from other countries with a range of incomes, they found that the CDR is more than 2 times and 6 times higher in the wealthiest countries relative to the upper-middle-class and low-income countries, respectively.

The number of deaths in women before the age of 70 is seen to be 15% higher in Colombia relative to Argentina, but in the case of men, the gap is only 5%. In other words, about 43% and 49% of COVID-19 deaths in Colombian women and men occurred before the age of 70. In Argentina, 29% of COVID-19 deaths in women and 44% in men were premature.

In terms of the standardized fatality ratio (SFR) and standardized partial death rate (SPDR), female: male fatality ratios moved closer, relative to the CFR. At the same time, Colombia displays a high SDPR for both sexes, at 69 and 154 in women and men, respectively. Argentina has an SDPR of 63 and ~125 for the sexes.

What are the Implications?

The study shows the importance of processing pandemic mortality data by age and sex, using viral statistics from the region or country.

A global analysis of mortality is not sufficient to apprehend the specific effect of the pandemic in each country, even in cases where one can assume that they are comparable.”

Ignoring the effects of age and sex while comparing death rates is thus likely to cause the real differences in fatality correlated with age and sex differences to be wrongly buried in the data.

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2020, December 08). COVID-19 mortality varies with demographic profile. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20201204/COVID-19-mortality-varies-with-demographic-profile.aspx.

  • MLA

    Thomas, Liji. "COVID-19 mortality varies with demographic profile". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20201204/COVID-19-mortality-varies-with-demographic-profile.aspx>.

  • Chicago

    Thomas, Liji. "COVID-19 mortality varies with demographic profile". News-Medical. https://www.news-medical.net/news/20201204/COVID-19-mortality-varies-with-demographic-profile.aspx. (accessed April 25, 2024).

  • Harvard

    Thomas, Liji. 2020. COVID-19 mortality varies with demographic profile. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20201204/COVID-19-mortality-varies-with-demographic-profile.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine promises broad protection against SARS-CoV-2 and other sarbecoviruses